JP Morgan Maintains Neutral on HCA Healthcare, Raises Price Target to $475

Benzinga · 1d ago
JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $425 to $475.